Harvard University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Harvard University sits in the top decile of US sponsors by registered trial count (#456 of 15,742 sponsors by registered trial count).

37 total trials 2 currently recruiting 32 completed early-phase tilt top decile by trial count

Harvard University: 37 sponsored US clinical trials, 2 recruiting.

Harvard University sponsors 37 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 32 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anxiety, with 4 trials.

Top-decile sponsor footprint

Harvard University ranks in the top decile of sponsors by registered trial count (#456 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 75/100

32 of 34 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

37 total, page 1 of 1

RECRUITING NA

Digital Single Session Intervention for Youth Mental Health

NCT05449002

RECRUITING NA

Testing FIRST in Youth Outpatient Psychotherapy

NCT04725721

ACTIVE NOT RECRUITING NA

Innovative Family Prevention With Latino Siblings in Disadvantaged Settings

NCT03706014

COMPLETED NA

Testing the Effects of Project Calm in Ukrainian Schools

NCT06217705

TERMINATED NA

Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 3)

NCT06114849

TERMINATED NA

Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 1)

NCT06114875

COMPLETED NA

The Ukrainian Student Problem Solving Project

NCT06064578

COMPLETED NA

Project THINK: Trial of a Brief Cognitive Restructuring Intervention

NCT05720741

COMPLETED NA

Music-based Mindfulness Intervention for Elevated Race-based Anxiety in the Black Community

NCT05746312

COMPLETED NA

iWellness Study to Evaluate a Mental Health App for Students

NCT05234970

COMPLETED NA

Patient Perceptions of Physician Education and Quality by Race

NCT04940234

COMPLETED NA

Willingness to Participate in Clinical Trials Among Black and African Americans

NCT04938895

COMPLETED NA

StriveWeekly Online Mental Health Trial Post-pandemic

NCT04927845

COMPLETED NA

Project SOLVE: Trial of a Brief Digital Problem-solving Intervention

NCT04806321

COMPLETED NA

Digital Narrative Bibliotherapy as a Scalable Intervention for Suicidal Thoughts

NCT05351645

COMPLETED NA

Minnesota COVID-19 Testing Project

NCT04568889

COMPLETED NA

A Mindful Community for People With ALS and Their Primary Caregivers

NCT05595850

COMPLETED NA

Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects

NCT04160975

COMPLETED NA

Mindful Attention to Variability in Everyday Memory

NCT03949868

COMPLETED NA

Mindfully Attending to Pain Sensations

NCT03939949

COMPLETED NA

Evaluating a Mobile App for Students Seeking Care for Depression and Anxiety at Harvard University Health Services

NCT03552900

COMPLETED NA

Brief Online Help-seeking Barrier Reduction Intervention

NCT03633825

COMPLETED NA

Attention to Variability During Infertility

NCT03712982

COMPLETED NA

Sugar Sweetened Beverage Labeling Support

NCT02947802

COMPLETED NA

Effects of a Single-session Implicit Theories of Personality Intervention on Early Adolescent Psychopathology

NCT03132298

COMPLETED NA

Using Neuroimaging to Understand Children's Mental Health and Treatment Outcomes

NCT03112265

COMPLETED NA

An Online Mindfulness Intervention for People With ALS and Their Caregivers

NCT03095989

COMPLETED NA

Student Outcomes of Integrative Mental Health Services

NCT02877875

COMPLETED NA

Connecticut Child STEPs

NCT03153904

COMPLETED NA

The Power of Curiosity: Leveraging Curiosity to Motivate People to Complete Health Risk Assessments

NCT01875913

COMPLETED NA

Social Network Interventions in Rural Honduras

NCT01672580

COMPLETED NA

Child STEPS for Youth Mental Health in Maine Sustainability

NCT03112304

COMPLETED NA

Lottery Incentives for Moving

NCT01278654

COMPLETED Phase 2

Couples Therapy for Alcoholic Patients

NCT01659957

COMPLETED NA

Testing Strategies for Increasing Exercise

NCT01139541

COMPLETED Phase 2

Behavioral Couples Therapy for Female Drug-Abusing Patients

NCT01189305

COMPLETED NA

Maine Implementation Study - Phase III

NCT02229305

What is open in the Harvard University pipeline

2 recruiting of 37 indexed (5% open); 32 completed (86%).

Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).

Top condition: Anxiety (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Harvard University: open-pipeline peers nationwide

Peers matched on 37 registered trials and 5% open enrollment, not the therapeutic-area sidebar.

Harvard University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 020406080 0%5%10%15% Total trials Recruiting share Harvard UniversityAppalachian State UniversityBracco DiagnosticsCarnegie Mellon UniversityCuteraC. R. BardDenver Health and Hospital AuthorityAlmirall, S.A.Cordis US
Harvard University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Harvard University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 37 trials (± recruiting share)

Sponsors near 5% open enrollment (± trial volume)

What to do with this Harvard University page

37 registered trials is a research-attention snapshot, not an endorsement of Harvard University or any single study.

  • 2 of Harvard University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Anxiety is the condition Harvard University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anxiety trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Harvard University pipeline card: 37 registered trials from official public datasets.Report a data error.